HK1001461A1 - Epstein-barr virus peptides and antibodies againstthese peptides. - Google Patents

Epstein-barr virus peptides and antibodies againstthese peptides.

Info

Publication number
HK1001461A1
HK1001461A1 HK98100042A HK98100042A HK1001461A1 HK 1001461 A1 HK1001461 A1 HK 1001461A1 HK 98100042 A HK98100042 A HK 98100042A HK 98100042 A HK98100042 A HK 98100042A HK 1001461 A1 HK1001461 A1 HK 1001461A1
Authority
HK
Hong Kong
Prior art keywords
antibodies
peptides
peptide
ebv
pct
Prior art date
Application number
HK98100042A
Other languages
English (en)
Inventor
Jaap Michiel Middeldorp
Original Assignee
Biomerieux Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerieux Bv filed Critical Biomerieux Bv
Publication of HK1001461A1 publication Critical patent/HK1001461A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/085—Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus
    • C07K16/087—Herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK98100042A 1992-09-14 1998-01-05 Epstein-barr virus peptides and antibodies againstthese peptides. HK1001461A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP92202797 1992-09-14
PCT/EP1993/002478 WO1994006912A1 (fr) 1992-09-14 1993-09-13 Peptides du virus d'epstein-barr et anticorps diriges contre ces peptides

Publications (1)

Publication Number Publication Date
HK1001461A1 true HK1001461A1 (en) 1998-06-19

Family

ID=8210912

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98100042A HK1001461A1 (en) 1992-09-14 1998-01-05 Epstein-barr virus peptides and antibodies againstthese peptides.

Country Status (13)

Country Link
US (1) US5965353A (fr)
EP (1) EP0607425B1 (fr)
JP (3) JP4155591B2 (fr)
KR (1) KR100384250B1 (fr)
AT (1) ATE266728T1 (fr)
AU (1) AU667745B2 (fr)
CA (1) CA2120342C (fr)
DE (1) DE69333511T2 (fr)
DK (1) DK0607425T3 (fr)
ES (1) ES2221922T3 (fr)
FI (1) FI114781B (fr)
HK (1) HK1001461A1 (fr)
WO (1) WO1994006912A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7888458B1 (en) * 1993-11-30 2011-02-15 John B. Harley Diagnostics and therapy of epstein-barr virus in autoimmune disorders
WO1996002563A1 (fr) * 1994-07-13 1996-02-01 Cornell Research Foundation, Inc. Proteine de l'antigene nucleaire 1 du virus epstein barr, son expression et sa recuperation
US7273613B1 (en) 1997-01-13 2007-09-25 The Board of Regents, The University of Oklahoma Diagnostics and therapy of Epstein-Barr virus in autoimmune disorders
AU766165B2 (en) * 1997-01-13 2003-10-09 Oklahoma Medical Research Foundation Diagnostics and therapy of Epstein-Barr virus in autoimmune disorders
ITMI20010445A1 (it) 2001-03-05 2002-09-05 Enitecnologie Spa Dispersioni acquose di residui petroliferi pesanti
AU2003246485A1 (en) * 2002-07-16 2004-02-02 Affinium Pharmaceuticals, Inc. Interactions of the epstein-barr virus protein ebna1, and uses thereof
WO2022146869A1 (fr) * 2020-12-29 2022-07-07 The Board Of Trustees Of The Leland Stanford Junior University Agents diagnostiques et thérapeutiques pour le virus epstein-barr (ebv) en sclérose en plaques (sep) et autres maladies auto-immunes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4654419A (en) * 1984-08-08 1987-03-31 Scripps Clinic And Research Foundation Synthetic polypeptides and antibodies related to epstein-barr virus nuclear antigen
US5717065A (en) * 1984-08-08 1998-02-10 The Scripps Research Institute Synthetic polypeptides and antibodies related to epstein-barr virus nuclear antigen
US5256768A (en) * 1985-12-13 1993-10-26 The Johns Hopkins University Expression of antigenic Epstein-Barr virus polypeptides in bacteria and their use in diagnostics
JPH04310861A (ja) * 1991-04-09 1992-11-02 Kazuo Yanagi 抗ｅｂｎａ抗体の測定方法および抗ｅｂｎａ抗体測定キット

Also Published As

Publication number Publication date
EP0607425B1 (fr) 2004-05-12
ATE266728T1 (de) 2004-05-15
DK0607425T3 (da) 2004-09-20
FI942184A0 (fi) 1994-05-11
FI942184A (fi) 1994-05-11
KR100384250B1 (ko) 2003-12-24
JP4368406B2 (ja) 2009-11-18
DE69333511T2 (de) 2005-05-12
US5965353A (en) 1999-10-12
JP2009280589A (ja) 2009-12-03
JP4155591B2 (ja) 2008-09-24
FI114781B (fi) 2004-12-31
JP4957974B2 (ja) 2012-06-20
AU4816293A (en) 1994-04-12
JPH07501710A (ja) 1995-02-23
EP0607425A1 (fr) 1994-07-27
CA2120342A1 (fr) 1994-03-31
ES2221922T3 (es) 2005-01-16
CA2120342C (fr) 2004-11-16
DE69333511D1 (de) 2004-06-17
AU667745B2 (en) 1996-04-04
WO1994006912A1 (fr) 1994-03-31
JP2008273972A (ja) 2008-11-13

Similar Documents

Publication Publication Date Title
HUP0103650A2 (hu) Vírusburok-proteinek epitópjai és az ellenük termelt ellenanyagok alkalmazása HCV-vírusantigén gazdaszövetből történő kimutatására
EP1318401A3 (fr) Méthode pour la détection précoce de la séroconversion d'un anticorps contre l'hépatite C virus
EP0769696A3 (fr) Anticorps et protéines d'essai d'une infection virale dans la vigne
ZA976196B (en) Peptide reagent for the detection of human cytomegalovirus (cmv)
EP0602046A4 (fr) Detection des virus de l'immunodeficience chez les mammiferes.
ZA964683B (en) Epstein-barr virus peptides and antibodies against these peptides
GR3018371T3 (en) Method for identifying or determining proteins and applications therefor.
HK1001461A1 (en) Epstein-barr virus peptides and antibodies againstthese peptides.
GB2246780B (en) Immunodiagnostic assay for rheumatoid arthritis
DE69534263D1 (de) Expression kassette eines proteines p30 aus toxoplasma gondii
FI102381B1 (fi) Epstein-Barrin viruksen tuma-antigeeniin (EBNA) liittyviä synteettisiä polypeptidejä ja menetelmä anti-EBNA-vasta-aineiden tunnistamiseksi kudosnäytteessä
CA2259967A1 (fr) Reactif de peptides permettant la detection de cytomegalovirus (cmv) humain
IT1250367B (it) Materiale proteico legante anticorpi contro il citomegalovirus umano e reagenti diagnostici derivati da tale materiale proteico.
RU2000124671A (ru) Эпитопы в белках вирусной оболочки и специфические антитела, направленные против этих эпитопов: применение для обнаружения антигена вируса hcv в ткани хозяина

Legal Events

Date Code Title Description
AS Change of ownership

Owner name: BIOMERIEUX B.V.

Free format text: FORMER OWNER(S): AKZO NOBEL N.V

PE Patent expired

Effective date: 20130912